Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,237 | -10,366 | -27,177 | -17,319 | -9,428 |
| Depreciation Amortization | 382 | 84 | 32 | 23 | 15 |
| Accounts payable and accrued liabilities | 1,056 | 398 | 320 | 67 | -367 |
| Other Working Capital | -3,253 | -1,258 | 1,036 | 1,088 | -682 |
| Other Operating Activity | 878 | 541 | 2,142 | 1,720 | 764 |
| Operating Cash Flow | $-21,174 | $-10,601 | $-23,647 | $-14,421 | $-9,698 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -277 | -10 | -36 | -544 | -531 |
| Net Acquisitions | N/A | N/A | -524 | N/A | N/A |
| Sale Of Investment | 4,385 | 2,986 | 2,492 | N/A | N/A |
| Investing Cash Flow | $4,108 | $2,976 | $1,932 | $-544 | $-531 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 8,000 | 8,000 | N/A |
| Debt Repayment | -90 | -45 | -169 | -125 | -84 |
| Common Stock Issued | 214 | N/A | 38,756 | N/A | N/A |
| Other Financing Activity | -162 | -15 | 31,157 | -741 | -482 |
| Financing Cash Flow | $-38 | $-60 | $77,744 | $7,134 | $-566 |
| Exchange Rate Effect | -35 | -14 | 118 | -24 | -4 |
| Beginning Cash Position | 73,770 | 73,770 | 17,623 | 17,623 | 17,623 |
| End Cash Position | 56,631 | 66,071 | 73,770 | 9,768 | 6,824 |
| Net Cash Flow | $-17,139 | $-7,699 | $56,147 | $-7,855 | $-10,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,174 | -10,601 | -23,647 | -14,421 | -9,698 |
| Capital Expenditure | -277 | -10 | -36 | -544 | -531 |
| Free Cash Flow | -21,451 | -10,611 | -23,683 | -14,965 | -10,229 |